T he intestinal immune system is charged with the task of maintaining immunological tolerance to the host's tissue as well as to bacterial and dietary Ags persistently encountered in the lumen. One mechanism by which oral tolerance ameliorates autoimmune disease is through the production of Th2-type cytokines (IL-4, IL-10, TGF-␤) by CD4 ϩ T cells, which, in turn, inhibit activation of Th1 cells that produce IFN-␥ and mediate cell-mediated immunity (1) . Because the relative proportions of Th1 and Th2 cells have such an impact on the host response, the factors controlling T cell differentiation are of interest.
IL-10 is a potent suppressor of macrophage function and leads to an inhibition of Th1-type cytokine production from T cells (2) . This immunoregulatory effect is associated with inhibiting the expression of class II MHC (3), reducing the production of proinflammatory cytokines such as IL-1, IL-6, and TNF-␣ (4), and down-regulating the expression of costimulatory molecules such as B7 (5) or ICAM-1 (6) on macrophages. IL-10 also plays a role in the maintenance of anergy in T cells activated by a primary mixed lymphocyte reaction (7) . The failure to develop tolerance to otherwise benign Ags that persist in the lumen may contribute to chronic inflammatory bowel disease, such as Crohn's disease or ulcerative colitis, in humans (8) . In fact, tolerance against autologous intestinal flora is broken in lamina propria lymphocytes isolated from active lesions of inflammatory bowel disease patients (9) or in mononuclear cells from spleen or intestine from mice with experimental colitis (10, 11) . Interestingly, tolerance toward autologous flora was restored by treatment with IL-10 or Abs to IL-12 in the murine model (10) .
Recent advances in genetic engineering have revealed several experimental models of colitis. For example, spontaneous colitis develops in mice in which there is a disruption of genes encoding IL-2 (12), TCR ␤-chain (13), TGF-␤ (14), or IL-10 (15). Moreover, the intestinal flora that is present in wild-type mice without colitis is sufficient to trigger enteric disease in the animals with these genetic disruptions (16 -19) . The role for flora as a trigger of colitis was also established in SCID mice reconstituted with CD45RB high CD4 ϩ lymphocytes (20) . Furthermore, disease in these animals was prevented when they were treated with exogenous IL-10 (21) or the transfer of T cells that express high levels of 23) . Because colitis is also induced after the transfer of CD4 ϩ T cells from IL-10-deficient mice to recombinase-activating gene-2-deficient mouse recipients exposed to a normal flora (24) , it is reasonable to suggest that IL-10 plays a key role in controlling the excessive immune responses to luminal flora.
The present study investigated the hypothesis that potentially destructive autoreactive responses can be induced by microbial Ags and that these responses are inhibited by IL-10. The results suggest that highly immunogenic stimuli, such as staphylococcal enterotoxin B (SEB), 3 are capable of inducing autoreactive T cells that express a repertoire that recognizes self Ags, proliferate in response to syngeneic cells, and are capable of injuring syngeneic cells through cell-mediated immunity. In addition, these responses are regulated by IL-10. The implications for the roles of these responses in immune-mediated disease of the intestine are discussed.
Materials and Methods

Mice
IL-10
Ϫ/Ϫ 129/SvEv mice (H-2 b , I-E Ϫ ) were provided by DNAX Research Institute (Palo Alto, CA) and were bred in the Animal Resource Center of the University of Texas Medical Branch (Galveston, TX). Wild-type 129/ SvEv mice were purchased from Taconic Farms (Germantown, NY) and were bred under the same conditions. C57BL/10 IL-10 Ϫ/Ϫ mice (H-2 b , I-E Ϫ , Mls-1 b ) and wild-type controls, CBA/J mice (H-2 k , Mls-1 a ), as well as C3H/HeJ mice were purchased from The Jackson Laboratory (Bar Harbor, ME). The animal research committee of the University of Texas Medical Branch approved all procedures used in these studies.
Cytokines and Abs
Recombinant murine IL-10 was provided by Schering-Plough (Kenilworth, NJ). Hybridomas producing anti-mouse CD8 (53-6.72, TIB-105) or antimouse I-A k (10.2.16, TIB-93) were purchased from American Type Culture Collection (Manassas, VA) and grown according to the instructions provided. Supernatants were used as a source of Ab. Anti-mouse I-E k , I-A b Ab (M5/114) were produced from ascites and were concentrated using ammonium sulfite sedimentation by Dr. Victor Reyes (University of Texas Medical Branch). Anti-IL-10R Ab (1B1.2) was provided by Dr. K. W. Moore (DNAX, Palo Alto, CA). The activity of rIL-10 and the neutralizing activity of this Ab were confirmed as previously described (25) using the IL-10-dependent mouse mast cell line (MC/9, American Type Culture Collection CRL 8306), in which 0.1 g/ml Ab inhibited the proliferation of 2 ϫ 10 4 MC/9 cells in the presence of 1 ng/ml mouse rIL-10 and 5 pg/ml mouse rIL-3 (data not shown). Isotype controls for mouse IgG (ChromPure Mouse IgG) and rat IgG (ChromPure Rat IgG) were purchased from Jackson ImmunoResearch Laboratories (West Grove, PA). PE-or FITC-conjugated anti-mouse CD3, CD4, or CD8 was purchased from Caltag (Burlingame, CA). FITC-conjugated anti-mouse V␤3, V␤6, V␤7, V␤8.1, V␤8.2, biotin-conjugated anti-mouse TCR-␣␤, PE-conjugated anti-mouse CD8, biotinylated-human IL-10 (26), and isotype controls for the corresponding Abs were obtained from PharMingen (San Diego, CA). Streptavidin-PE was purchased from Sigma (St. Louis, MO).
Cell isolation
Single-cell preparations were made by mincing spleen and lysing RBC in ammoniun chloride (0.15 M), potassium carborate (1 nM), and EDTA (0.1 nM) buffer (pH 7.3) lysing buffer; using standard techniques (27) . Colonic mucosal T cells were isolated using a modification of a previously described procedure (28) . Briefly, large intestines from five C3H/HeJ mice were isolated and flushed, lymphoid nodules were removed, and tissue was opened longitudinally in HBSS (Life Technologies, Grand Island, NY). Tissue was cut into 2-to 5-mm segments and stirred at 37°C for 45 min in DMEM containing 50 U/ml of type VIII collagenase (Sigma), 0.5 mg/ml of dispase grade II (Roche, Indianapolis, IN), 0.01% gentamicin (Life Technologies), and 5% FCS. After collecting the cell suspension in the supernatant, the enzymatic treatment was repeated again. Pooled supernatants were filtered through nylon wool, and enriched lymphocytes were centrifuged through a discontinuous 44/70% Percoll (Pharmacia, Alameda, CA) gradient for 18 min at 800 ϫ g at 4°C. Cells at the interface between the 70 and 44% layers were collected and washed. Approximately 95% of the lymphocytes were viable, as measured by trypan blue exclusion.
T cell stimulation
T cells prepared from spleen or colon (2.5 ϫ 10 6 cells/ml) were stimulated with 10 g/ml SEB (Sigma) in RPMI 1640 (Life Technologies) containing 10% FCS (HyClone, Logan, UT) as a primary stimulation. After 72 h of incubation the cells were washed three times to remove the residual SEB and resuspended in 10 g/ml SEB in RPMI 1640. After 4 days of resting, cells were washed once, and 2 ϫ 10 5 viable responder cells were cultured with 2.5 ϫ 10 5 syngeneic feeder cells in 96-well flat-bottom plates. Feeder cells were prepared by incubating fresh splenocytes with 100 g/ml of mitomycin C (Sigma) at 37°C for 30 min and washing three times. In some experiments recombinant mouse IL-10 and/or anti-IL-10R Ab (1B1.2) was added in either the priming or secondary stimulation. T cells were also activated with anti-CD-3 or PMA (5 ng/ml) and ionomycin (500 ng/ml; Sigma) as previously described (29) 
Purification of T cells
In some experiments MHC class II ϩ cells and/or CD8 ϩ cells were depleted to obtain highly enriched CD4 ϩ T cells (30 
Flow cytometry of surface Ag expression
One million cells were incubated in PBS-0.1% azide containing fluorescence-or biotin-conjugated Abs on ice for 30 min. When using biotinconjugated Abs, cells were washed once and incubated with streptavidin-PE for 20 min on ice. After being washed three times, cells were fixed in 1% paraformaldehyde and analyzed by FACScan (Becton Dickinson, San Jose, CA).
Cytokine assay
The IL-2 concentration of culture supernatant was detected by bioassay using the CTLL-2 hybridoma (27) . Cells (5000/50 l medium) were incubated with 50 l of samples or standards (recombinant human IL-2, Genzyme, Cambridge, MA) in triplicate for 24 h. [ 3 H]thymidine (1 Ci/ well) was added during the last 8 h of incubation, and [
3 H]thymidine incorporation was detected as described above. Specific IL-2 activity (units per milliliter) was calculated according to the standard curve of the identical assay.
Cytotoxicity assay
The cytotoxic activity of SEB-primed effector cells (splenocytes or colonic mucosal lymphocytes) was detected by the JAM assay (31) using Mode-K cells (duodenal epithelial cell line from C3H/HeJ origin (32)) as target cells. Effector cells from C3H/HeJ mice were stimulated with 10 g/ml of SEB for 18 h, washed three times, and used as effector cells. In some experiments cells were pretreated with recombinant mouse IL-10 and/or anti-IL-10R Ab (1B1.2) for 2 h before addition of SEB. Mode-K cells were labeled with 10 Ci/ml of 
Statistical analysis
Paired Student's t test (two tailed) was performed to compare the mean values of two corresponding datasets.
Results
Induction of autoreactive T cells by SEB
To determine whether activation of splenic T cells by a microbial Ag could induce autoreactive responses, splenocytes from IL-10 KO (C57BL/10) or wild-type mice were primed with SEB in vitro (Fig. 1) . The primary proliferative response to 10 g/ml of SEB of splenocytes from IL-10 KO mice was comparable to that of wildtype splenocytes. SEB-primed splenocytes from C57BL/10 mice showed a significant proliferative response after secondary culture with mitomycin C-treated syngeneic feeder cells. The magnitude of the secondary response in IL-10-deficient mice of the same strain was comparable to that of wild-type mice. In contrast, medium-primed splenocytes from wild-type mice did not respond to the secondary stimulation with the syngeneic feeders, whereas those from IL-10-deficient mice underwent a significant proliferation in response to the syngeneic feeders, albeit less than that observed after priming with SEB. Interestingly, 67.6 Ϯ 5.2 U of IL-2 were produced in the supernatant of SEB-primed splenocytes from IL-10-deficient mice, which was higher than that in wild-type (46.1 Ϯ 3.1). Adding recombinant mouse IL-10 (10 -100 ng/ml) to the culture suppressed the IL-2 production of both IL-10 KO and wild-type splenocytes, whereas the constitutive proliferative response observed in IL-10 KO mice was not affected. These data indicate that priming with SEB induced autoreactive proliferative responses, and IL-10-deficient cells tend to be autoreactive without priming (Fig. 1) .
IL-10 inhibits the autologous response in both induction and effector phases
We examined the possibility that IL-10 regulates the induction of the autoreactive response by SEB in several strains of mice. Splenocytes from three different strains of mice were primed with SEB in the presence or the absence of recombinant mouse IL-10, and secondary autoreactive responses to the syngeneic feeder cells were detected. Although the magnitude of the secondary response varied among strains, IL-10 in the primary culture significantly inhibited the autoreactive response in the 129 and CBA/J mice ( Fig. 2A) . We also examined whether IL-10 inhibited the autoreactive response of SEB-primed cells (Fig. 2B) . Adding IL-10 to the secondary culture of SEB-primed cells suppressed the autoreactive response in all strains. This inhibition was confirmed to be IL-10 specific, since the effect of IL-10 was completely abrogated by addition of anti-IL-10R Ab, but not by isotype control, in C57BL/10 and 129/SvEv strain. Interestingly, this Ab was not effective in the CBA/J strain, suggesting heterogeneity of the structure of IL-10R in CBA/J mice.
To confirm that IL-10 was mediating as specific effect through the IL-10R, responder cells were assayed for binding of IL-10 by flow cytometry. Resting or SEB-stimulated T cells from spleen or colon expressed IL-10R, as evidenced by IL-10 binding (Fig. 2C) , or mRNA, detected by RT-PCR (data not shown). Binding of IL-10 did not change with stimulation.
Polyclonal stimuli induce autoreactivity
As SEB, which stimulates about 20% of T cells, induced autoreactivity, we examined the hypothesis that polyclonal stimuli in general have a potential to induce autoreactivity. Splenocytes from CBA/J mice were primed with SEB as well as anti-CD3 or PMA plus ionomycin, and secondary responses to the feeder cells were detected. All these polyclonal stimuli induced the secondary autoreactive responses, and these responses were inhibited by IL-10 in the secondary cultures (Fig. 3) . Ag-specific stimulation with OVA did not induce the secondary response (data not shown).
SEB expands T cell populations expressing an autoreactive repertoire in Mls-1 a mice
To (Fig.  4) . Splenocytes from C3H/HeJ mice (Mls-1 b ) also had more V␤6 ϩ or V␤7 ϩ T cells after expansion in response to SEB. V␤8.1 ϩ T cells are depleted in Mls-1 a strains; however, we detected 9% of V␤8 cells in the freshly isolated splenocytes from both CBA/J and C3H/HeJ strains, because the Ab also recognizes V␤8.2 ϩ cells. Expansion of this population was also observed in the T cell lines. In other experiments anti-Mls-1a Ab (33) partially inhibited the secondary response of SEB-primed CBA/J cells, suggesting that part of the autoreactive response was directed toward the Mls-1 a Ag itself (data not shown). These data provide direct evidence that priming with superantigen abrogated self tolerance and expanded autoreactive T cells in vitro.
Autoreactive T cells responses are mediated by CD4 ϩ T cell responses
Because Th cells are capable of transferring disease in several models of colitis, the role of CD4
ϩ Th cells in the secondary autoreactive response was determined. CD8-depleted cells showed FIGURE 1. SEB induces proliferative responses to self Ags. Spleen cells from C57BL/10 IL-10-deficient and wild-type mice were primed with 10 g/ml SEB or medium for 3 days. Subsequently, primed cells were incubated with medium alone or with syngeneic feeder cells, and secondary proliferative responses were detected. SEB-primed splenocytes showed significant autoreactive response after secondary stimulation with syngeneic feeder cells. Medium-primed IL-10-deficient splenocytes also showed autoreactive responses. Data are expressed as the mean Ϯ SEM for nine observations from three independent experiments. ‫,ء‬ p Ͻ 0.05 for the mean proliferative response to syngeneic feeders without priming compared with their response to medium alone. ‫,ءء‬ p Ͻ 0.05 for the mean proliferative response to syngeneic feeders after priming with SEB vs medium alone. a comparable level of secondary response as the splenocyte preparation (Fig. 5A) . Moreover, addition of anti-MHC class II Ab to the secondary culture, but not an isotype control Ab, significantly blocked the autoreactive response in all three strains examined (Fig. 5B ). These observations suggest that CD4 ϩ T cells mediated the autoreactive response. Adding IL-10 in the primary or secondary culture of CD8-depleted cells suppressed the secondary response, indicating that the regulatory effect of IL-10 was independent of the presence of CD8 ϩ T cells (Fig. 5A) .
Priming conditions for autoreactive T cells stimulate cellmediated immunity to epithelial targets
To address the possibility that autoreactive T cells may be able to contribute to epithelial cell damage and inflammation in the digestive tract, Mode-K cells were used as a target for cell-mediated immunity. Splenocytes from C3H/HeJ mice (syngeneic to Mode-K) were stimulated with SEB for 18 h and checked for a cytotoxic effect by JAM assay. Fig. 6A shows that SEB-stimulated splenocytes as well as CD8-depleted cells mediated cytotoxic activity against the Mode-K target cells. Supernatant from SEB-stimulated splenocytes did not kill the target (data not shown). Furthermore, the cytotoxic effect was abolished when a culture insert was used to separate effector and target cells, indicating that this cytotoxicity was facilitated by direct contact with the target cells. Because most of the cytotoxic activity resided in the CD4 ϩ T cells, colonic mucosal T cells, which include intestinal intraepithelial epithelial lymphocytes (IEL) and lamina propria lymphocytes (LPL) that contain increased proportions of CD4 (36), were stimulated with SEB and tested for cytotoxicity. Examination of surface Ags revealed that Ͼ75% of the cells were CD3, CD4 ϩ , confirming the phenotype of colonic IEL described by others (36, 37) . As shown in Fig. 6B , SEB-activated colonic mucosal T cells kill the syngeneic epithelial cell target. Moreover, this cytotoxicity was inhibited by the addition of IL-10, and the Ab recognizing the IL-10R (1B1.2) blocked the inhibition.
Discussion
Microbial Ags are quite capable of activating intestinal T cells in humans (9) and mice (10, 11) . Recently, SEB has been shown to cross the intestinal epithelial cell barrier (38) and stimulate T cells (39 -41) , leading to the activation of T cells producing IFN-␥ and IL-2 (42) . Based on the results presented in this report, any stimulation that activates a relatively large subset of T cells generates autoreactive T cells that proliferate when re-exposed to self Ags expressing class II MHC. Moreover, these autoreactive cells are cytolytic to epithelial cells in vitro.
The autoreactive cells induced by SEB included CD4 ϩ T cells, because most of the primed cells contained CD4 ϩ TCR␣␤ ϩ phenotypes detected by FACS analysis. Depletion of CD8 ϩ cells before priming did not attenuate the autoreactivity. Moreover, this autoreactivity was mediated by MHC class II molecules on the feeder cells, because this reaction was inhibited by anti-MHC class II Abs. These findings support the idea that the autoreactive cells are CD4 ϩ T cells. As activated T cells may express only modest amounts of class II MHC, the T cells are not capable of long term expansion in the absence of feeder cells. Moreover, because SEB induces the expression of FasL on T cells, it is likely that, in time, activation will lead to a negative selection of the T cells as they die due to Fas/FasL interactions (43) . The magnitude of the proliferative responses varied among strains of mice, but they were present in all strains tested. In addition, autoreactive T cells could be generated from spleen or colon, which supports our previous preliminary studies suggesting that these responses occur in gutassociated lymphoid tissue, including the mesenteric lymph nodes or intestinal Peyer's patches (44) . CD4 ϩ autoreactive T cells prepared from the spleens of IL-10-deficient mice displayed a level of spontaneous autoreactivity without prior priming with SEB. Despite this intrinsic autoreactivity, stimulation with SEB did not increase the response to levels greater than those observed in control mice. This somewhat unanticipated finding may reflect a ceiling for autoreactivity that is ϩ cells in freshly isolated splenic T cells from CBA/J were depleted due to the expression of the endogenous viral superantigen. However, the percentage of T cells bearing these V␤-chains increased to 14 and 6%, respectively, after stimulation. This observation provided direct evidence that priming with SEB expanded autoreactive T cell populations. ϩ T cells were depleted from CBA/J splenocytes using anti-CD8 Ab (53-6.72) followed by sheep anti-rat IgG-coated magnet beads, yielding highly enriched preparations of CD4 ϩ T cells. Total spleen cells and equal numbers of CD8-depleted cells were primed with SEB followed by resting and secondary culture with feeders. CD8-depleted cells showed comparable secondary response as the total spleen cells, suggesting that CD4 ϩ T cells were autoreactive. Adding IL-10 to the primary or secondary culture of CD8-depleted cells inhibited the secondary autoreactive response. ‫,ء‬ p Ͻ 0.05 for SEB-primed cells exposed to feeders vs medium. defined by the number of autoreactive precursors and the magnitude of their expansion. It should be remembered that normally, autoreactive cells are almost nonexistent, so any increase may be quite significant. This is supported by the observation that adoptive transfer of these T cells into T cell-deficient mice can induce colitis in the recipient (24) . These observations suggest that IL-10 confers a protective effect against the activation of autoreactive T cells induced by normal flora. Although there was no difference between IL-10-deficient and wild-type mice in the level of secondary autoreactive responses after priming with SEB, exogenous IL-10 suppressed the autoreactivity, including both proliferative and cytolytic effects, when delivered during the priming or secondary stimulation. IL-10R were expressed on both T cells and cells of other lineages, so the inhibitory activity of IL-10 may have been mediated at different levels.
The specificity of the effect of IL-10 was confirmed by blocking the IL-10R with anti-IL-10R Ab. This Ab was effective in the 129/SvEv and C57BL/10 strains, but not in the CBA/J strain. Interestingly, IL-10 inhibited IL-2 production in the C57BL/10 and 129SvEv strains after stimulation with SEB, but not in CBA/J mice (data not shown). Heterogeneity of cell surface molecule among mouse strains has been reported for CD8 (45) , IL-4R (46), or FasL (47), which affects not only the recognition by mAbs but also the function of the molecules. Our observations suggest that there is heterogeneity in the structure and function of the IL-10R; however, further experimentation is necessary to precisely evaluate the basis for the inability of the Ab to inhibit IL-10 responses in CBA/J mice.
Regulation of autoreactivity in the priming phase by IL-10 is consistent with the finding that supplementation of IL-10 prevented the development of colitis in IL-10-deficient mice (48) or in the CD45RB high transfer model (22, 23) . IL-10 also suppressed autoreactivity in the secondary culture. Endogenous IL-10 produced from feeder cells seemed to be insufficient to inhibit the autoreactivity, because secondary proliferative responses were similar whether the feeder cells were obtained from IL-10-deficient or control mice.
Although proliferation in response to syngeneic feeders provides evidence that SEB can abrogate tolerance, it is possible that the proliferative response was not directed to self Ags, but, rather, to residual SEB or some factor in the growth medium. The possibility that residual SEB in the primed cells was restimulating the responder cells was discounted for several reasons: 1) the responder cells contained only a marginal number of APC, which might carry over SEB into the secondary stimulation, because SEB induced only a limited proliferation to the responder cells without adding fresh feeder cells; 2) responder cells could be maintained for up to 12 wk after repeated washing and restimulation with syngeneic feeder cells, suggesting that little residual SEB was carried over; and 3) the autologous response was significantly inhibited by IL-10, but IL-10 did not inhibit the proliferative response caused by SEB. The fact that T cells from IL-10-deficient mice were capable of modest proliferative responses upon stimulation with syngeneic Ags without priming suggests that the responses were indeed autoreactive. Although it is possible that xenogenic proteins in the growth medium, such as those provided by FCS, may be presented by feeders, small amounts of proliferation were still observed when cultures were maintained in mouse serum (data not shown). However, the most direct evidence for the expansion of autoreactive cells was the expression of autoreactive T cell repertoires.
To address the affect of SEB on T cells that bear autoreactive repertoires, the well-characterized murine model of TCR repertoires to endogenous viral superantigens was employed. Mls-1 has been known to act as a minor lymphocyte-stimulating Ag. Subsequently, the Mls-1 Ag was shown to be encoded by the mtv-7 gene, which is a murine mammary tumor viral gene that has integrated into their genome of some strains of mice (34) . These mice are referred to as Mls-1 a mice, while mice lacking this Ag are Mls-1 b . It is known that specific T cells in Mls-1 b mice bearing specific TCR ␤-chains (i.e., V␤6 and V␤7) proliferate in response to this Ag. Because the Mls-1 Ag is expressed on host cells, these T cells are deleted in Mls-1 a mice. The results described in this report show that SEB could expand the number of T cells from Mls-1 a mice that bear this autoreactive repertoire. Although most of these autoreactive T cells are deleted during T cell development, this process is imperfect, leading to the escape of potentially autoreactive clones. The intestinal intraepithelial lymphocyte compartment is particularly enriched with T cells expressing these autoreactive TCRs (49, 50) . Because Mls-1 Ag can be expressed on intestinal epithelial cells (51) , autoreactivity of T cells recognizing this Ag must be prevented by a state of anergy. However, cytokines, such as IL-2, can abrogate anergy in autoreactive IEL (29, 52) . Zinkernagel and colleagues (53) have also shown that transgenic T cells expressing a receptor recognizing a transgenic viral peptide that is expressed on pancreatic ␤ islet cells remain anergic. However, upon stimulation with virus infection, the anergic T cells react to viral Ag and induce diabetes. Thus, presentation of a microbial Ag in an immunogenic fashion can induce autoreactivity that can contribute to disease. This may be due to antigenic mimicry between the pathogen and the host Ag or the activation of autoreactive T cells due to the burst of cytokines, such as IL-2, that are released during the infection.
Having established that autoreactive T cells can expand after exposure to SEB, we showed that these cells were capable of inducing damage to host cells. As described in Fig. 6 , T cells from the spleen or colon that were activated with SEB could induce death and DNA degradation in Mode-K cells. Because SEB induces the expression of FasL on T cells (43) , it is possible that apoptosis of epithelial cells was mediated by interactions between Fas and FasL. This model is supported by the results of other studies documenting the expression of Fas on epithelial cells and FasL by intestinal T cells in graft-vs-host disease (54, 55) . Previous reports have suggested that changes in epithelial cell structure and function can occur after exposing tissue to SEB (41, 56) . The ability of SEB to induce cytokines (42) as well as apoptosis in epithelial cells following exposure to SEB may contribute to the T cell-mediated pathology.
As described above, colitis in many animal models is dependent on normal flora, and T cells recognizing luminal microbial Ags become activated during colitis. Moreover, adoptive transfer of T cells from colitic mice will lead to colitis in T cell-deficient recipients. These studies suggest that microbial triggers activate a deleterious T cell response; however, a role for autoreactive T cells has not been implicated previously. In this report we show that a microbial superantigen, SEB, is capable of inducing autoreactive T cells in systemic and colonic tissue and that this response is prevented by IL-10. Additional studies are required to determine the relative contribution of this process to chronic inflammatory diseases in the digestive tract.
